Mastodon
Dept. of Clinical… MBL MBL-Leistungsbereich…

DEVELOPMENT OF PK/PD BIOMARKERS

FOR THE INDIVDUALIZATION OF DRUG THERAPY

Forschungsschwerpunkt

We develop and validate
1. phosphorylation of a protein in the NO-cGMP pathway as a diagnostic and therapeutic marker in endothelial dysfunction,
2. exosomes as biomarkers for drug clearance.

Mission

Biomarker development for precision dosing

Background

Appropriate biomarkers are often not available for a precise individual drug dosing.



Most visited


EN